NDC 70677-0153-01 - Ibuprofen Oral
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70677-0153
- Requested NDC
- 70677-0153-01
- Package NDCs from labels
- 70677-0153-1, 70677-0153-01
- Manufacturer
- Strategic Sourcing Services | AptaPharma Inc.
- Effective date
- 2022-08-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ibuprofen Oral Suspension USP, 100 mg/5 mL (OTC) | Strategic Sourcing Services | AptaPharma Inc. | 2022-08-10 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70677-0153-1 | Ibuprofen Oral | 118 mL in 1 BOTTLE | SUSPENSION | 118 | 1 | |
| 70677-0153-1 | Ibuprofen Oral | 1 in 1 CARTON | SUSPENSION | 1 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70677-0153 | IBUPROFEN ORAL (IBUPROFEN ORAL) SUSPENSION [STRATEGIC SOURCING SERVICES] | 1 | Current NDC, Legacy NDC, 2 package rows | 20220811_a3062142-db0e-4758-a762-2b2bb05670b1.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70677-0153-1 | ML - Milliliter | 70677-0153 | b4e8be0e-e5f7-4a79-9455-79aaa2fb6e4f | 1 | 2023-02-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glycerin | GLYCERIN | Chain Drug Consortium LLC | 4694f05b-d927-4e15-9630-a0a1cddb3cbb | 2025-10-16 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Amerisource Bergen/Good Neighbor Pharmacy | e6a8914f-cfd9-4c72-abaa-22189bf0faef | 2025-10-16 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Chain Drug Marketing Association Inc. | 3386fada-6b7f-46fd-e063-6294a90abffc | 2025-10-16 | Warnings | PDC6A3C0OX |
| IBUPROFEN AND FAMOTIDINE | IBUPROFEN AND FAMOTIDINE | PHOENIX RX LLC | 3ff33400-30e8-87fa-e063-6394a90a7f5c | 2025-10-15 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Advanced Rx of Tennessee, LLC | 41351cc0-5ec6-2f4d-e063-6294a90a733a | 2025-10-15 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Finafta | BENZOCAINE, GLYCERIN | Efficient Laboratories Inc. | 03368603-3e11-c2fa-e063-6294a90a04ea | 2025-10-14 | Warnings | PDC6A3C0OX |
| childrens ibuprofen | IBUPROFEN | Safeway | 6dbf5acc-46a1-4d5b-a9a6-9b77f106d711 | 2025-10-14 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Direct_rx | 1be33b4f-4987-580f-e063-6294a90a3103 | 2025-10-13 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Coupler LLC | 410f7320-4caa-8f88-e063-6394a90acf93 | 2025-10-13 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Preferred Pharmaceuticals Inc. | a85080d7-50b4-461b-9d77-d6fbab971c03 | 2025-10-13 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Rite Aid Corporation | 1dba3cb7-2e3d-4378-93cf-92db8f24f41f | 2025-10-09 | Warnings | WK2XYI10QM |
| Glycerin | GLYCERIN | H E B | 3d0566a1-57a5-6a31-e054-00144ff88e88 | 2025-10-09 | Warnings | PDC6A3C0OX |
| RIGHT REMEDIES Ibuprofen 200 MG | IBUPROFEN | Strive Pharmaceuticals Inc. | 5c155210-d16f-487e-983d-c7b0f97365c6 | 2025-10-08 | Warnings | WK2XYI10QM |
| Childrens Motrin | IBUPROFEN | Kenvue Brands LLC | 63ec7636-bf2a-4d52-ab88-fb93d41661ec | 2025-10-08 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | CHAIN DRUG MARKETING ASSOCIATION INC | 6521bc47-4d9c-4a5b-b109-3841f3be4b6c | 2025-10-07 | Warnings | WK2XYI10QM |
| Childrens Motrin | IBUPROFEN | Kenvue Brands LLC | 15b0b56d-6188-4937-b541-902022e35b24 | 2025-10-07 | Warnings | WK2XYI10QM |
| Mitochondria PRO | ARALIA QUINQUEFOLIA, ARNICA MONTANA, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ALPHA-KETOGLUTARICUM ACIDUM, ASCORBICUM ACIDUM, ALPHA-LIPOICUM ACIDUM, CALCAREA CARBONICA, CITRICUM ACIDUM, CUPRUM METALLICUM, CYSTEINUM, FERRUM METALLICUM, IODIUM, LEVOTHYROXINUM, MAGNESIUM GLUCONICUM DIHYDRICUM, MALICUM ACIDUM, MANGANUM ACETICUM, NADIDUM, NATRUM PYRUVICUM, NICOTINAMIDUM, PYRIDOXINUM HYDROCHLORICUM, RIBOFLAVINUM, SELENIUM METALLICUM, SULPHUR, THIAMINUM HYDROCHLORICUM, UBIDECARENONUM, ZINCUM METALLICUM, | Energique, Inc. | 8c3e961d-bc33-40cd-a282-a4fe5aa3f0ad | 2025-10-06 | Warnings | XF417D3PSL |
| Kidnex IV | GINKGO BILOBA, ALPHA-KETOGLUTARICUM ACIDUM, CITRICUM ACIDUM, FUMARICUM ACIDUM, MALICUM ACIDUM, PYRUVIC ACID, SUCCINICUM ACIDUM, ARGENTUM METALLICUM, AURUM METALLICUM, CUPRUM METALLICUM, GERMANIUM SESQUIOXIDE, MERCURIUS VIVUS, NUX VOMICA, KIDNEY (SUIS), LYMPH NODE (SUIS), NAPHTHOCHINONUM, NATRUM OXALACETICUM, PHOSPHORUS, URINARY BLADDER (SUIS), ACONITICUM ACIDUM, CIS- | Energique, Inc. | 121eb51a-befe-47ea-85c6-d77e8c7e5864 | 2025-10-06 | Warnings | XF417D3PSL |
| Motrin IB | IBUPROFEN | Kenvue Brands LLC | d21129f8-4d96-4e36-bc39-a534306dd77e | 2025-10-03 | Warnings | WK2XYI10QM |
| Advil Multi-Symptom Cold and Flu | CHLORPHENIRAMINE MALEATE, IBUPROFEN, PHENYLEPHRINE HCL | Haleon US Holdings LLC | 7671d104-3c5c-4f63-b6b1-6c91c22592f8 | 2025-10-03 | Warnings | WK2XYI10QM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.